From the 1University of Chicago, Chicago, IL
2Rush University Medical Center, Chicago, IL
3Brigham and Women's Hospital, Harvard Medical School, Boston, MA
4Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA
5University of Colorado School of Medicine, Aurora, CO.
Received April 22, 2022; revised and accepted August 1, 2022.
Presentations at meetings: Oral Presenter at 16 World Congress on Menopause. Race/Ethnic Differences in Treatment of Menopausal Symptoms and Perceived Quality of Life in the Study of Women's Health Across the Nation (SWAN), June 6, 2018, Vancouver Canada.
Abstract Poster The North American Menopause Society (NAMS) Annual Meeting. Race/Ethnic Variation in Treatment of Menopausal Symptoms: A Longitudinal Analysis of the Initiation, Duration, and Quality of Life in the Study of Women's Health Across the Nation (SWAN), October 4, 2018, San Diego, CA.
Funding/support: Faculty Diversity Career Advancement Grant awarded to Monica Christmas, and internal funds from the Obstetrics & Gynecology Department University of Chicago.
The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR), and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495, U19AG063720). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or the NIH.
Financial disclosure/conflicts of interest: Christmas reports Board of Trustees for The North American Menopause Society (NAMS), NAMS Scientific Program Committee, NAMS Editorial Board, Steering Committee for Core OutcoMes in MenopAuse (COMMA), Speaker Alliance Chicago and FDA Bone, Reproductive and Urologic Division (BRUDAC) Committee. Joffe receives grant support from the National Institutes of Health, Merck, and Pfizer. She serves/has served as a consultant to Bayer, Jazz, and Eisai. Her institution received funding from NeRRE/KaNDy and Que Oncology. Her spouse is an employee at Arsenal Biosciences and has equity in Merck. Santoro reports advisory board member for Astellas, Que Oncology, Amazon (Ember), and Menogenix Inc; consultant for Ansh Labs; NAMS Program Committee; past president Society for Reproductive Investigation; and nominating committee Endocrine Society. The other authors have nothing to disclose.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s Website (www.menopause.org).
Address correspondence to: Monica Christmas, MD, 5841 S Maryland MC2050, Chicago, IL 60637. E-mail: [email protected]
